ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation).
Fuster
Valentin
V
American College of Cardiology, Bethesda, MD 20814, USA.
Rydén
Lars E
LE
Cannom
David S
DS
Crijns
Harry J
HJ
Curtis
Anne B
AB
Ellenbogen
Kenneth A
KA
Halperin
Jonathan L
JL
Le Heuzey
Jean-Yves
JY
Kay
G Neal
GN
Lowe
James E
JE
Olsson
S Bertil
SB
Prystowsky
Eric N
EN
Tamargo
Juan Luis
JL
Wann
Samuel
S
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002303:Cardiac Output, Low; D009202:Cardiomyopathies / Q000150:complications; D017115:Catheter Ablation; D016757:Death, Sudden, Cardiac / Q000209:etiology* / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D006323:Heart Arrest / Q000209:etiology / Q000628:therapy; D006334:Heart Function Tests; D006801:Humans; D017180:Tachycardia, Ventricular / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D014693:Ventricular Fibrillation / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents